On Tuesday, July 1st 2025, Protavio’s co‑founder and National Technical University of Athens professor, Dr. Leonidas Alexopoulos, spoke at the 2nd Synergies Forum on Cancer – Policy, Research & Funding Strategies, hosted by the Hellenic Cancer Federation (ELL.O.K.). Gathering policy‑makers, clinicians, researchers and patient advocates explored how joint investment and collaboration can modernise every stage of the cancer pathway, from prevention to survivorship.
Taking the stage in the panel “Prolamvano: Investing in Prevention – Strengthening Public Health,” Dr. Alexopoulos challenged delegates to rethink early‑detection strategies. Drawing on two decades of systems‑biology research, he showcased how multiplex protein diagnostics and AI‑driven biomarker discovery are converging into a new generation of routine blood tests capable of detecting diseases early. He noted that making screening as easy as a routine blood draw can remove socioeconomic barriers and that this shift from treatment to prevention is crucial for bending the cancer curve.
Dr. Alexopoulos also outlined Protavio’s mission to bridge the significant gap between laboratory discovery and clinical application. By combining proprietary multiplex technology with advanced machine‑learning algorithms, Protavio’s assays analyse biomarker signatures rather than single markers, achieving markedly higher sensitivity and specificity. The company’s pipeline of assay development, scalable manufacturing and real‑world evidence generation, was described as a model for translating research into equitable health outcomes.
Another highlight of the forum was ELLOK’s designation as Greece’s National Cancer Mission Hub under the EU‑funded ECHoS programme, joining the first five member states tasked with accelerating Europe’s Beating Cancer Plan. ELLOK President George Kapetanakis hailed the hub as a catalyst that unites researchers, clinicians, innovators, patients and policy‑makers in one mission: transforming how our society prevents, detects, treats and lives with cancer.
Protavio extends its thanks to the organisers and all the participants. Together with the new National Cancer Mission Hub, we look forward to shifting the needle from treatment to true prevention, delivering earlier diagnoses, better prognoses and healthier futures for everyone.